RxSight, Inc. RXST
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -18.97% | 0.31% | -18.48% | -18.91% | -14.09% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -18.97% | 0.31% | -18.48% | -18.91% | -14.09% |
| Cost of Revenue | 6.12% | -7.01% | -22.69% | -35.72% | -39.44% |
| Gross Profit | -25.29% | 2.76% | -17.05% | -12.24% | -3.94% |
| SG&A Expenses | 0.22% | 4.98% | 11.24% | -2.09% | 6.78% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.38% | -0.27% | 0.32% | -10.03% | -4.54% |
| Operating Income | -52.06% | 1.66% | -67.03% | -31.40% | -32.00% |
| Income Before Tax | -65.16% | -2.17% | -94.30% | -54.35% | -55.04% |
| Income Tax Expenses | 180.00% | 175.00% | -66.67% | -58.33% | -23.08% |
| Earnings from Continuing Operations | -65.28% | -2.64% | -93.94% | -54.13% | -54.88% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -65.28% | -2.64% | -93.94% | -54.13% | -54.88% |
| EBIT | -52.06% | 1.66% | -67.03% | -31.40% | -32.00% |
| EBITDA | -55.32% | 3.38% | -71.70% | -29.25% | -39.92% |
| EPS Basic | -62.35% | -0.80% | -90.16% | -51.12% | -50.41% |
| Normalized Basic EPS | -62.23% | -0.33% | -90.48% | -51.20% | -50.50% |
| EPS Diluted | -62.35% | -0.80% | -90.16% | -51.12% | -50.41% |
| Normalized Diluted EPS | -62.23% | -0.33% | -90.48% | -51.20% | -50.50% |
| Average Basic Shares Outstanding | 1.81% | 1.83% | 1.97% | 2.03% | 2.96% |
| Average Diluted Shares Outstanding | 1.81% | 1.83% | 1.97% | 2.03% | 2.96% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |